CN1969992B - 用于治疗痤疮的药物组合物及其实施方法 - Google Patents
用于治疗痤疮的药物组合物及其实施方法 Download PDFInfo
- Publication number
- CN1969992B CN1969992B CN2006101443182A CN200610144318A CN1969992B CN 1969992 B CN1969992 B CN 1969992B CN 2006101443182 A CN2006101443182 A CN 2006101443182A CN 200610144318 A CN200610144318 A CN 200610144318A CN 1969992 B CN1969992 B CN 1969992B
- Authority
- CN
- China
- Prior art keywords
- radix
- treatment
- pharmaceutical composition
- acne
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 17
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 15
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 11
- 238000000034 method Methods 0.000 title abstract description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 13
- 239000011593 sulfur Substances 0.000 claims abstract description 13
- 230000003115 biocidal effect Effects 0.000 claims abstract description 8
- 241000218628 Ginkgo Species 0.000 claims description 16
- 235000011201 Ginkgo Nutrition 0.000 claims description 16
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 15
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 7
- 206010040943 Skin Ulcer Diseases 0.000 claims description 6
- 229960003405 ciprofloxacin Drugs 0.000 claims description 6
- 229960002227 clindamycin Drugs 0.000 claims description 6
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims description 6
- 231100000019 skin ulcer Toxicity 0.000 claims description 6
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 claims description 5
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 claims description 5
- 229960002549 enoxacin Drugs 0.000 claims description 5
- 229960005287 lincomycin Drugs 0.000 claims description 5
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 3
- -1 or inuncts Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 35
- 239000000203 mixture Substances 0.000 abstract description 14
- 229940079593 drug Drugs 0.000 abstract description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 8
- 238000000053 physical method Methods 0.000 abstract description 4
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 4
- 244000247747 Coptis groenlandica Species 0.000 abstract description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract description 2
- 241000758993 Equisetidae Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- 230000000767 anti-ulcer Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229910052567 struvite Inorganic materials 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- 229920000832 Cutin Polymers 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- SHGAZHPCJJPHSC-UHFFFAOYSA-N Panrexin Chemical compound OC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000003470 adrenal cortex hormone Substances 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 230000002402 anti-lipaemic effect Effects 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000882890 Renova Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006003 cornification Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 229940059527 renova Drugs 0.000 description 1
- 229940002683 retin-a Drugs 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101443182A CN1969992B (zh) | 2006-12-01 | 2006-12-01 | 用于治疗痤疮的药物组合物及其实施方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101443182A CN1969992B (zh) | 2006-12-01 | 2006-12-01 | 用于治疗痤疮的药物组合物及其实施方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1969992A CN1969992A (zh) | 2007-05-30 |
CN1969992B true CN1969992B (zh) | 2010-12-08 |
Family
ID=38111140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101443182A Expired - Fee Related CN1969992B (zh) | 2006-12-01 | 2006-12-01 | 用于治疗痤疮的药物组合物及其实施方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1969992B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101416987B (zh) * | 2008-03-19 | 2011-06-22 | 朱光勇 | 一种蜂蜜酸合剂和制备方法及其应用 |
CN104225535A (zh) * | 2014-09-18 | 2014-12-24 | 董云 | 一种治疗囊肿性痤疮、毛囊周围炎的药物 |
CN104306890A (zh) * | 2014-10-30 | 2015-01-28 | 路云香 | 一种用于治疗痤疮的中药 |
CN105031159B (zh) * | 2015-06-19 | 2019-01-08 | 昆明贝泰妮生物科技有限公司 | 一种具有祛痘功效的中药提取物制剂及其制备方法 |
CN106266453A (zh) * | 2016-08-31 | 2017-01-04 | 郑向东 | 一种皮肤外用组合物及其应用 |
CN110237156A (zh) * | 2019-06-05 | 2019-09-17 | 营口银泉科技有限公司 | 一种祛痘药物组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1137389A (zh) * | 1995-06-06 | 1996-12-11 | 赵可新 | 治疗痤疮的外用药及其乳剂的制备方法 |
CN1157160A (zh) * | 1996-12-06 | 1997-08-20 | 王化石 | 一种治疗痤疮的中成药 |
CN1236634A (zh) * | 1998-05-22 | 1999-12-01 | 李华 | 多功能痤疮药液及其制备方法 |
-
2006
- 2006-12-01 CN CN2006101443182A patent/CN1969992B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1137389A (zh) * | 1995-06-06 | 1996-12-11 | 赵可新 | 治疗痤疮的外用药及其乳剂的制备方法 |
CN1157160A (zh) * | 1996-12-06 | 1997-08-20 | 王化石 | 一种治疗痤疮的中成药 |
CN1236634A (zh) * | 1998-05-22 | 1999-12-01 | 李华 | 多功能痤疮药液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1969992A (zh) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101167847B (zh) | 一种有效治疗皮肤病的中药白酒制剂 | |
CN105833279B (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
CN1969992B (zh) | 用于治疗痤疮的药物组合物及其实施方法 | |
CN103989869A (zh) | 一种治疗皮肤创伤的中药组合物及其用途 | |
CN101485727A (zh) | 一种治疗冻疮的外用酊剂 | |
CN102406766B (zh) | 一种治疗骨折的中药组合物及其应用 | |
CN102824449B (zh) | 一种治疗褥疮、创口感染、糖尿病皮肤病的外用酊剂 | |
CN101264240A (zh) | 一种治疗脚癣的外用药物 | |
CN103536850B (zh) | 一种内外兼治治疗扁平疣的中药药物 | |
CN105106745A (zh) | 一种清创中药洗剂 | |
CN105055721A (zh) | 一种用于祛除头皮屑的中药组合物及其制备方法 | |
CN1969960A (zh) | 用于治疗痤疮的药物组合物及其实施方法 | |
CN103638193B (zh) | 一种用于痤疮的中药及其制备方法 | |
CN108721442B (zh) | 治疗烧烫伤及尿布皮炎的中药组合物、制剂及其制备方法 | |
CN102380038A (zh) | 一种治疗淋巴结核的药物和火针疗法 | |
CN100584365C (zh) | 用于治疗痤疮的药物组合物 | |
CN101172129A (zh) | 治疗皮下瘀斑的中药组合物及其制备方法 | |
CN1814218A (zh) | 激素皮炎外敷剂 | |
CN104721384A (zh) | 一种收敛药膏 | |
CN103463611B (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
CN100525796C (zh) | 用于治疗痤疮兼具美容效果的药物组合物 | |
CN105326972A (zh) | 一种治疗外伤、疮疡的外用药物组合物 | |
CN101011482A (zh) | 用于治疗痤疮的药物组合物 | |
CN104189204A (zh) | 一种用于治疗毛囊炎的中药洗液 | |
CN105770626A (zh) | 一种治疗毛囊炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU BAITENG TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: CHANG DAFEI Effective date: 20120621 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100086 HAIDIAN, BEIJING TO: 213164 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120621 Address after: 213164 building four, block B, building 1, Changzhou science and Education City, Jiangsu Patentee after: Jiangsu 5ipatent Technology Co.,Ltd. Address before: 100086, Beijing Academy of Sciences, Zhongguancun southeast district, 916 floor, 2 door, room 1203 Patentee before: Chang Dafei |
|
ASS | Succession or assignment of patent right |
Owner name: HAIMEN JIANGYONG INVESTMENT AND DEVELOPMENT CO., L Free format text: FORMER OWNER: JIANGSU BAITENG TECHNOLOGY CO., LTD. Effective date: 20130917 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 226133 CHANGZHOU, JIANGSU PROVINCE TO: 226133 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130917 Address after: 226133, No. 118, Renmin East Road, Linjiang Town, Haimen, Jiangsu, Nantong Patentee after: Haimen Jiang Yong Investment & Development Co., Ltd. Address before: 226133 building four, block B, building 1, Changzhou science and Education City, Jiangsu Patentee before: Jiangsu 5ipatent Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101208 Termination date: 20151201 |
|
EXPY | Termination of patent right or utility model |